New Vision-Saving drug challenges standard treatment for blinding eye disease
Disease control
Not yet recruiting
This study is testing whether a new eye injection called tiespectus works as well as the current standard treatment (aflibercept) for wet age-related macular degeneration, a leading cause of vision loss in older adults. Researchers will enroll 960 people who haven't received trea…
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC